ORASURE TECHNOLOGIES, INC Income (Loss) from Continuing Operations before Income Taxes, Domestic
ORASURE TECHNOLOGIES, INC (OSUR) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$62.74 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$62.74M.
- ORASURE TECHNOLOGIES, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$21.52M, a 134.90% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $61.67M.
- ORASURE TECHNOLOGIES, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$7.11M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$62.74M 10-K · filed 2026-03-09 | |
| 2024-12-31 | -$21.52M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $61.67M 10-K · filed 2026-03-09 | |
| 2022-12-31 | -$7.11M 10-K · filed 2025-03-07 | -$7.91M 10-K · filed 2023-03-03 |
| 2021-12-31 | -$60.50M 10-K · filed 2024-03-11 | |
| 2020-12-31 | -$47.99M 10-K · filed 2023-03-03 | |
| 2019-12-31 | $3.11M 10-K · filed 2022-03-01 | |
| 2018-12-31 | -$11.73M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $2.27M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $18.49M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $5.30M 10-K · filed 2018-02-28 | |
| 2014-12-31 | -$6.16M 10-K · filed 2017-03-14 | -$8.28M 10-K · filed 2015-03-12 |
| 2013-12-31 | -$10.55M 10-K · filed 2016-03-14 | |
| 2012-12-31 | -$13.52M 10-K · filed 2015-03-12 | |
| 2011-12-31 | -$8.15M 10-K · filed 2014-03-14 | |
| 2010-12-31 | -$3.50M 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |